A. M. Pappas &a; Associates

AMP, a California-based start-up building audio processing technologies to empower people to hear better in their everyday lives.

Business Model:

Revenue: $9.5M

Employees: 11-50

Rankings

Detailed A. M. Pappas &a; Associates Information

Geographic Data

A. M. Pappas &a; Associates headquarters map

Address: 2520 Meridian Pkwy

City: Durham

State: NC

Zip: 27713

Country: US

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$0

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

M. Pappas &a; Associates is a venture capital firm investing in and nurturing promising companies, products, technologies, ventures, and other significant entrepreneurial opportunities. Currently, it has 350 million U.S. dollars in capital under management and has invested in more than 65 portfolio companies in the United States and Canada. While its focus is on serving investors and entrepreneurs, the firm also supports philanthropic interests in the realms of life sciences, public education, and entrepreneurial endeavors. M. Pappas &a; Associates manages three lines of business that include Pappas Ventures, manages a family of life science venture capital funds, whose portfolio companies include Ultragenyx Pharmaceutical, Chimerix, TESARO, TYRX, and Lumena Pharmaceuticals; specialized fund management, leverages its experience, expertise, and network on behalf of highly targeted investment fund opportunities; and translational medicine initiatives, envisions an opportunity to place A. M. Pappas &a; Associates at the nexus between researchers, university tech transfer offices, pharmaceutical companies, and disease-focused philanthropic organizations to select, guide, and manage academic-based translational product candidates to early development milestones that will attract private investment or industry interest.

Contact Phone:
+19199983300

Contact Email:

Announced Date Company Transaction Money Raised
7/2002 Sensys Medical Series D 0
10/2000 Elitra Pharmaceuticals Venture Round 0
11/2002 Dynogen Pharmaceuticals Series A 13.3M
5/2004 Panacos Pharmaceuticals Post-IPO Equity 0
5/2005 Asstrodyne TDI Series C 26.4M
10/2002 Peninsula Pharmaceuticals Series B 0
9/2003 Selventa Series A 0
11/2002 Bloodhound Software Series E 0
1/2003 Emerald BioAgriculture Corporation Venture Round 0
3/2000 Variagenics Funding Round 19M
8/2005 Cerexa Inc. Series A 0
7/2005 BrainCells Series A 0
8/2000 Novalon Pharmaceutical Venture Round -
5/2004 Plexxikon Series B 0
8/2003 LipoScience Series E 15M
2/2002 Syntonix Pharmaceuticals Series B 35.8M
9/2008 CeNeRx BioPharma Series B 15M
1/1999 Copernicus Therapeutics Venture Round 0
7/2001 Cognetix Series B 0
1/2004 Peninsula Pharmaceuticals Series C 0
9/2008 CeNeRx BioPharma Series B 0
8/2005 Cerexa Inc. Series A 0
7/2005 BrainCells Series A 0
5/2005 Asstrodyne TDI Series C 0
5/2004 Plexxikon Series B 0
5/2004 Panacos Pharmaceuticals Post-IPO Equity 0
1/2004 Peninsula Pharmaceuticals Series C 0
9/2003 Selventa Series A 0
8/2003 LipoScience Series E 0
1/2003 Emerald BioAgriculture Corporation Venture Round 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research